Skip to main content
SpringerLink
Log in
Book cover

Melanocytic Lesions pp 437–459Cite as

Molecular Ancillary Techniques

  • Chapter
  • First Online:

  • 881 Accesses

Abstract

In the setting of ambiguous melanocytic proliferations, the utility of ancillary molecular techniques is still controversial. Currently ancillary techniques such as comparative genomic hybridization and fluorescence in situ hybridization cannot replace conventional microscopy. Detailed morphological evaluation of the lesion remains paramount in the diagnosis of the overwhelming majority of pigmented lesions.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm Jr MC, et al. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol. 1999;30(5):513–20.

    Article  CAS  PubMed  Google Scholar 

  • Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol. 2000;157(3):967–72.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther. 2006;19(1):40–9.

    Article  PubMed  Google Scholar 

  • Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, et al. KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res. 2008;14(21):6821–8. doi:10.1158/1078-0432.CCR-08-0575.

    Article  CAS  PubMed  Google Scholar 

  • Boi S, Leonardi E, Fasanella S, Cantaloni C, Micciolo R. The four-color FISH probe in the diagnosis of melanocytic lesions. J Eur Acad Dermatol Venereol. 2010;24(10):1235–6.

    Article  CAS  PubMed  Google Scholar 

  • Braun-Falco M, Schempp W, Weyers W. Molecular diagnosis in dermatopathology: what makes sense, and what doesn’t. Exp Dermatol. 2009;18(1):12–23.

    Article  CAS  PubMed  Google Scholar 

  • Busam KJ, Fang Y, Jhanwar SC, Pulitzer MP, Marr B, Abramson DH. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization. J Cutan Pathol. 2010;37(2):196–203.

    Article  PubMed  Google Scholar 

  • Clemente C, Bettio D, Venci A, Scopsi L, Rao S, Ferrari A, et al. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions. Pathologica. 2009;101(5):169–74.

    CAS  PubMed  Google Scholar 

  • Dalton SR, Gerami P, Kolaitis NA, Charzan S, Werling R, LeBoit PE, Bastian BC. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am J Surg Pathol. 2010;34(2):231–7.

    Article  PubMed Central  PubMed  Google Scholar 

  • Fang Y, Dusza S, Jhanwar S, Busam KJ. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status. Int J Surg Pathol. 2012;20(5):434–40.

    Article  PubMed  Google Scholar 

  • Gaiser T, Kutzner H, Palmedo G, Siegelin MD, Wiesner T, Bruckner T, et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod Pathol. 2010;23(3):413–9. doi:10.1038/modpathol.2009.177.

    Article  CAS  PubMed  Google Scholar 

  • Gammon B, Beilfuss B, Guitart J, Busam KJ, Gerami P. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma. J Cutan Pathol. 2011;38(4):335–41.

    PubMed  Google Scholar 

  • Gammon B, Beilfuss B, Guitart J, Gerami P. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Am J Surg Pathol. 2012;36(1):81–8.

    Article  PubMed  Google Scholar 

  • Gerami P, Jewell SS, Morrison LE, Blondin B, Schulz J, Ruffalo T, et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol. 2009a;33(8):1146–56.

    Article  PubMed  Google Scholar 

  • Gerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol. 2009b;33(12):1783–8.

    Article  PubMed  Google Scholar 

  • Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. Arch Dermatol. 2010;146(3):273–8.

    Article  PubMed  Google Scholar 

  • Gerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J Cutan Pathol. 2011a;38(4):329–34.

    Article  PubMed  Google Scholar 

  • Gerami P, Jewell SS, Pouryazdanparast P, Wayne JD, Haghighat Z, Busam KJ, et al. Copy number gains in 11q13 and 8q24 are highly linked to prognosis in cutaneous malignant melanoma. J Mol Diagn. 2011b;13(3):352–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hossain D, Qian J, Adupe J, Drewnowska K, Bostwick DG. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization. Melanoma Res. 2011;21(5):426–30.

    Article  PubMed  Google Scholar 

  • Hung T, Piris A, Lobo A, Mihm Jr MC, Sober AJ, Tsao H, et al. Sentinel lymph node metastasis is not predictive of poor outcome in patients with problematic spitzoid melanocytic tumors. Hum Pathol. 2013;44:87–94. doi:10.1016/j.humpath.2012.04.019.

    Article  PubMed  Google Scholar 

  • Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, et al. High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol. 2006;126(9):2111–8.

    Article  CAS  PubMed  Google Scholar 

  • Jakob JA, Bassett Jr RL, Ng CS, Curry JL, Joseph RW, Alvarado GC, et al. NRAS mutation status is an independent prognostic factor in metastatic melanoma. Cancer. 2012;118(16):4014023.

    Article  Google Scholar 

  • Lee JH, Choi JW, Kim YS. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanomas: a meta-analysis. Br J Dermatol. 2011;164(4):776–84.

    Article  CAS  PubMed  Google Scholar 

  • Ludgate MW, Fullen DR, Lee J, Lowe L, Bradford C, Geiger J, et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2009;115(3):631–41.

    Article  PubMed  Google Scholar 

  • Magro CM, Crowson AN, Mihm Jr MC, Gupta K, Walker MJ, Solomon G. The dermal-based borderline melanocytic tumor: a categorical approach. J Am Acad Dermatol. 2010;62(3):469–79.

    Article  PubMed  Google Scholar 

  • Massi D, Cesinaro AM, Tomasini C, Paglierani M, Bettelli S, Dal Maso L, et al. Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. J Am Acad Dermatol. 2011;64(5):919–35.

    Article  PubMed  Google Scholar 

  • Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridization. Pathology. 2009;41(4):383–7.

    Article  CAS  PubMed  Google Scholar 

  • Newman MD, Lertsburapa T, Mirzabeigi M, Mafee M, Guitart J, Gerami P. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Mod Pathol. 2009;22(8):989–95.

    Article  CAS  PubMed  Google Scholar 

  • Ohmholt K, Grafstrom E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res. 2011;17(12):3933–42.

    Article  Google Scholar 

  • Pouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am J Surg Pathol. 2009;33(9):1396–400.

    Article  PubMed  Google Scholar 

  • Raskin L, Ludgate M, Iyer RK, Ackley TE, Bradford CR, Johnson TM, Fullen DR. Copy number variations and clinical outcome in atypical Spitz tumors. Am J Surg Pathol. 2011;35(2):243–52.

    Article  PubMed  Google Scholar 

  • Reed RJ. Atypical Spitz nevus/tumor. Hum Pathol. 1999;30(12):1523–6.

    Article  CAS  PubMed  Google Scholar 

  • Reed RJ. Minimal deviation melanoma. Borderline and intermediate melanocytic neoplasia. Clin Lab Med. 2000;20(4):745–58.

    CAS  PubMed  Google Scholar 

  • Urso C. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer. 2010;116(1):258.

    PubMed  Google Scholar 

  • Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O’Brien JM, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457(7229):599–602.

    Article  PubMed Central  PubMed  Google Scholar 

  • Vergier B, Prochazkova-Carlotti M, De la Fouchardiere A, Cerroni L, Massi D, De Giorgi V, et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod Pathol. 2011;24(5):613–23.

    Article  CAS  PubMed  Google Scholar 

  • Weisner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol. 2012;36(6):818–30.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, Boston, MA, USA

    Mai P. Hoang MD, Adriano Piris MD & Martin C. Mihm Jr. MD

  2. Department of Pathology, Massachusetts General Hospital, 55 Fruit Street Warren 820, Boston, MA, 02114, USA

    Mai P. Hoang MD & Adriano Piris MD

  3. Department of Dermatology, Brigham and Women’s Hospital, Boston, MA, USA

    Martin C. Mihm Jr. MD

  4. Melanoma Program, Dana Farber Brigham and Women’s Cancer Center, 41 Louis Pasteur Avenue, Room 317B, Boston, MA, 02115, USA

    Martin C. Mihm Jr. MD

Authors
  1. Mai P. Hoang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adriano Piris MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martin C. Mihm Jr. MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Mai P. Hoang MD or Martin C. Mihm Jr. MD .

Editor information

Editors and Affiliations

  1. Massachusetts General Hospital, Department of Pathology Harvard Medical School, Boston, Massachusetts, USA

    Mai P. Hoang

  2. Brigham and Women’s Hospital, Deptartment of Pathology, Harvard Med School Melanoma Program in Dermatology, Boston, Massachusetts, USA

    Martin C. Mihm Jr.

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hoang, M.P., Piris, A., Mihm, M.C. (2014). Molecular Ancillary Techniques. In: Hoang, M., Mihm Jr., M. (eds) Melanocytic Lesions. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0891-2_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0891-2_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0890-5

  • Online ISBN: 978-1-4939-0891-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation